MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
MiniMed Group Inc MMED
$20.04
▼ -2.20%
($-0.45)
📉 Near 52W Low
🔥 High Short Interest
Open
$20.31
Prev Close
$20.49
Day Range
$19.73 – $20.37
52W Range
$10.65 – $24.43
Market Cap
$5.64B
Beta
0.15
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2026-03-06 |
| Shares Out. | 280,840,000 |
| Phone | 13026365401 |
| Employees | 2,800 |
| Website | minimed.com ↗ |
| Revenue | $843.0M |
| Gross Profit | $465.0M |
| Net Income | $0 |
| Total Assets | $4.72B |
| Total Liabilities | $1.10B |
| Equity | $3.62B |
About MiniMed Group Inc
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.
MiniMed Group Inc is a publicly traded company under the ticker symbol MMED on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-09-01)
📰 Latest News for MMED
Squeeze Watch: 10 Stocks With Over 33% Short Interest
Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29
MiniMed Group, Inc. (MMED) Presents at Bank of America Global Healthcare Conference 2026 Transcript
MiniMed (MMED): Nine Analysts Raised Targets, But Cash Flow Still Has a Catch